Jump to content

Synnovis

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Belbury (talk | contribs) at 18:46, 12 March 2023 (move rebrand to history). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Synnovis, formerly Viapath, is a London-based provider of pathology services. It is a partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust, and SYNLAB UK & Ireland.[1]

Services

Synnovis provides pathology services to The Princess Royal University Hospital as well as to Guy's, St Thomas’ and King's College hospitals.[2] The laboratories are accredited with the ISO 15189 medical laboratory standard and are listed by UKAS.[3][4]

History

Synnovis was established under the name of GSTS Pathology in 2009 as a partnership with Serco.[5] It was founded in response to the recommendations in the “Report of the Review of NHS Pathology Services in England” chaired by Lord Carter of Coles, published in 2006.[6] GSTS Pathology posted a £5.9 million loss in 2011 but a £3.8m net profit for the year ending December 2013, up from £300,000 in 2012. Income increased by 6% from £87.6m in 2012 to £92.5m in 2013.[7] In 2014 the majority-owned NHS joint venture rebranded itself Viapath when it merged with Kingspath.

In January 2014, Viapath began operating as three different entities: Viapath Group, Viapath Analytics and Viapath Services. Viapath Group enables the provision of an end-to-end pathology service including laboratory testing services, laboratory facilities and equipment, logistics, IT and corporate support services.

In February 2016, Dr. David Bennett, former head of NHS Foundation Trust regulator Monitor, was appointed the new chair of Viapath.[8] In July 2016, Dr. Dominic Harrington won the ‘Academy for Healthcare Science award for innovation’ at the Advancing Healthcare Awards. He was recognised for his achievement in creating Viapath’s Innovation Academy.[9]

In 2016, response to the government’s new Apprenticeship Levy scheme, Viapath partnered with 3aaa Apprenticeships to train apprentices under Viapath’s new VIAcademy scheme.[10]

In 2018, in conjunction with the Academy of Healthcare Science, the “Viapath Award For Innovation In Healthcare Science” was created, a category that was open to all UK healthcare scientists. The winners were Jonathan Ashmore and Cormac McGrath, clinical scientists from NHS Highlands and Belfast Health and Social Care Trust for their work on developing an MRI virtual reality app.[11]

Following successful trials, in 2018, Viapath agreed to implement diagnostics.ai's technology into Viapath's South London Specialist Virology Centre at King's College Hospital. This technology automates the analysis and reporting of results.[12]

When the company lost its bid for a renewal of the 15-year contract, the Guy's and St. Thomas' and King's College trusts bought out Serco's share.[13]

The Synnovis brand was launched in October 2022.[14]

NHS overcharging

Internal documents leaked to Corporate Watch in August 2014 indicate that the company overcharged the NHS for diagnostic tests. A 2013 internal audit by Guy's into three of the 15 laboratories run by Viapath found its invoicing and billing systems were “unreliable” and contained “material inaccuracies”, amounting to an overcharge of £283,561 over a sample three-month period. A variety of complaints by clinicians were recorded, centring on a policy of employing staff who were less experienced and less expensive. In a review of its first four years, marked “strictly confidential”, Chief Executive Richard Jones admitted that it had “achieved much less than hoped” and that “initial attempts at transformation were badly handled and ended up costing money rather than saving it”.[15]

References

  1. ^ "About Synnovis". Viapath. Retrieved 20 November 2022.
  2. ^ "Viapath - a New Brand, Same Commitment to Transform Pathology Services". Select Science. 9 May 2014. Retrieved 28 May 2014.
  3. ^ "Search Accredited Organisations". UKAS.
  4. ^ "Viapath Group LLP". www.cqc.org.uk.
  5. ^ "Serco and Guy's and St. Thomas' NHS Foundation Trust sign pioneering pathology partnership". 30 January 2009. Retrieved 5 April 2011.
  6. ^ "Report of the review of NHS pathology services in England".
  7. ^ "Pioneering pathology joint venture posts multi-million pound profit". Health Service Journal. 6 May 2014. Retrieved 27 May 2014.
  8. ^ "David Bennett moves to Viapath". www.pathologyinpractice.com.
  9. ^ "Viapath wins major UK award for its Innovation Academy". April 20, 2016.
  10. ^ "3aaa Apprenticeships".
  11. ^ "ahpandhsawards.co.uk" (PDF). www.ahpandhsawards.co.uk. Archived from the original (PDF) on 2018-06-14.
  12. ^ "Viapath to Automate and Digitise Their Molecular Diagnostics". www.rapidmicrobiology.com.
  13. ^ "Trusts to buy Serco out of joint venture after losing major contrac". Health Service Journal. 18 June 2020. Retrieved 2 August 2020.
  14. ^ "Launch of Synnovis brand is a key development for pathology partnership in London". Pathology in Practice. 4 October 2022. Retrieved 20 November 2022.
  15. ^ "Overcharging by outsourcing giant Serco costs NHS millions". Independent. 27 August 2014. Archived from the original on 2022-08-17. Retrieved 27 August 2014.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Synnovis&oldid=1144259897"